Factors including economics, environment, and demographic and social factors might put rural residents at a higher risk of these preventable causes of death.
The US Food and Drug Administration has determined that varenicline and bupropion pose a lower risk of serious mental health side effects than was previously thought.
Compared with men who never used tobacco, those who used snus but did not smoke had a 24% higher risk of death from prostate cancer.
Researchers find heavy users have lower bone density than cigarette smokers.
Cigarette smoking prevalence among persons with severe mental illness is approximately 3 times greater than the rate observed in the general population.
Maternal tobacco smoking during pregnancy has previously been linked with numerous long-term neurodevelopmental abnormalities and child behavioral problems.
Varenicline is approved by the FDA for use as a smoking cessation aid.
Researchers analyzed smoking behavior of 1 470 veterans who enrolled in the SmokefreeVET tobacco cessation program between 2013 and 2014.
At 12 months, researchers found a significant association between smoking reduction and suicidality.
Bipolar disorder (BD) is typically characterized by recurrent episodes of mania and depression, but the connection between BD and anxiety needs to be considered.
Psychiatry Advisor Articles
- Naltrexone-Assisted Detox vs Buprenorphine Taper for Opioid Dependence
- Suicide Prevention and Intervention: Cross-Cultural Perspectives
- Pediatric Patients Should Undergo Electrocardiogram Assessment Before Antipsychotic Treatment
- Which Antidepressants May Cause Birth Defects?
- Best Practices for Treatment of Bipolar Disorder